Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

SEOVF

Sernova Biotherapeutics Inc

USD

Set alert

Price alert · SEOVF

All alert types
0.08 USD 0.00 0.00%
As of Oct 30, 2026
0.0759 Day range 0.0759
0.06 52-week range 0.14
YTD
-11.11%
1 year
-27.27%
Open
0.0759
Prev close
0.08
Mkt cap
30.21M
Vol
458
Avg vol
83.70K
EPS
0.01
P/E
8.00
More statistics
Low
0.0759
High
0.0759

5D chart

Chart tools
Interval
1m5m15m30m

Chart is warming up

The five-day price history for SEOVF has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

-766.22 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

3 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C2 / 5 overall

  • DCF 1
  • Return on Equity 5
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 1
  • P/B 1

Valuation

P/E -3.3×
FY 2016: -13.9×FY 2017: -12.9×FY 2018: -9.1×FY 2019: -10.0×FY 2020: -8.9×FY 2021: -41.6×FY 2022: -9.0×FY 2023: -6.1×FY 2024: -2.6×FY 2025: -3.3×
FY 2016 5y median -6.1× FY 2025
P/S 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
P/B -2.1×
FY 2016: 7.6×FY 2017: 11.2×FY 2018: 8.9×FY 2019: 7.2×FY 2020: 12.7×FY 2021: 10.9×FY 2022: 4.6×FY 2023: 19.1×FY 2024: -6.1×FY 2025: -2.1×
FY 2016 5y median 4.6× FY 2025
P/FCF -4.8×
FY 2016: -16.0×FY 2017: -13.6×FY 2018: -7.2×FY 2019: -8.4×FY 2020: -10.6×FY 2021: -44.7×FY 2022: -14.8×FY 2023: -7.9×FY 2024: -4.2×FY 2025: -4.8×
FY 2016 5y median -7.9× FY 2025
EV/EBITDA -4.7×
FY 2016: -14.5×FY 2017: -15.0×FY 2018: -7.6×FY 2019: -8.6×FY 2020: -9.9×FY 2021: -42.3×FY 2022: -8.9×FY 2023: -5.7×FY 2024: -2.3×FY 2025: -4.7×
FY 2016 5y median -5.7× FY 2025
EV/Sales 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
FCF Yield -20.9%
FY 2016: -6.3%FY 2017: -7.3%FY 2018: -13.8%FY 2019: -12.0%FY 2020: -9.4%FY 2021: -2.2%FY 2022: -6.7%FY 2023: -12.7%FY 2024: -24.1%FY 2025: -20.9%
FY 2016 5y median -12.7% FY 2025

Profitability

Gross Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
ROE 63.0%
FY 2016: -46.5%FY 2017: -72.3%FY 2018: -113.3%FY 2019: -81.3%FY 2020: -128.4%FY 2021: -24.8%FY 2022: -51.3%FY 2023: -311.6%FY 2024: 248.5%FY 2025: 63.0%
FY 2016 5y median -24.8% FY 2025
ROIC 192.8%
FY 2016: -45.9%FY 2017: -70.9%FY 2018: -112.7%FY 2019: -81.3%FY 2020: -107.7%FY 2021: -24.1%FY 2022: -53.1%FY 2023: -320.0%FY 2024: 257.0%FY 2025: 192.8%
FY 2016 5y median -24.1% FY 2025
ROA -2060.0%
FY 2016: -40.2%FY 2017: -58.0%FY 2018: -102.6%FY 2019: -71.3%FY 2020: -92.9%FY 2021: -23.4%FY 2022: -46.5%FY 2023: -176.4%FY 2024: -427.7%FY 2025: -2060.0%
FY 2016 5y median -176.4% FY 2025

Growth (YoY)

Revenue 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 FY 2025
Operating Income 52.8%
FY 2016: 19.0%FY 2017: -4.8%FY 2018: -42.1%FY 2019: -7.9%FY 2020: -31.5%FY 2021: -31.5%FY 2022: -270.3%FY 2023: -61.8%FY 2024: 22.6%FY 2025: 52.8%
FY 2016 FY 2025
EPS (diluted) 52.1%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: -50.0%FY 2021: 0.0%FY 2022: -197.7%FY 2023: -45.6%FY 2024: 23.1%FY 2025: 52.1%
FY 2016 FY 2025
Free Cash Flow 42.3%
FY 2016: -14.3%FY 2017: -16.3%FY 2018: -34.7%FY 2019: -4.6%FY 2020: -17.3%FY 2021: -38.8%FY 2022: -115.0%FY 2023: -106.4%FY 2024: 37.9%FY 2025: 42.3%
FY 2016 FY 2025

Financial Health

Current Ratio 0.0×
FY 2016: 7.3×FY 2017: 4.8×FY 2018: 9.7×FY 2019: 7.7×FY 2020: 5.2×FY 2021: 19.2×FY 2022: 10.8×FY 2023: 2.2×FY 2024: 0.3×FY 2025: 0.0×
FY 2016 5y median 2.2× FY 2025
Quick Ratio 0.0×
FY 2016: 7.3×FY 2017: 4.8×FY 2018: 9.7×FY 2019: 7.7×FY 2020: 5.2×FY 2021: 19.2×FY 2022: 10.8×FY 2023: 2.2×FY 2024: 0.3×FY 2025: 0.0×
FY 2016 5y median 2.2× FY 2025
Debt / Equity -0.7×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.2×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: -0.0×FY 2025: -0.7×
FY 2016 5y median 0.0× FY 2025
Net Debt / EBITDA -1.2×
FY 2016: 2.1×FY 2017: 1.0×FY 2018: 0.5×FY 2019: 0.5×FY 2020: 0.6×FY 2021: 4.2×FY 2022: 0.1×FY 2023: 0.2×FY 2024: 0.2×FY 2025: -1.2×
FY 2016 5y median 0.2× FY 2025
Interest Coverage -19.9×
FY 2016: -255×FY 2017: -187×FY 2018: -379×FY 2019: -546×FY 2020: -60.5×FY 2021: -118×FY 2022: -215×FY 2023: -1282×FY 2024: -161×FY 2025: -19.9×
FY 2016 5y median -161× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-10-31